Cohort Study of Patients With Type 1 Diabetes Registered With Mobile Application in China

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-30

Study Completion Date

2032-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

For last decade, the innovation of mobile health platform has brought new opportunities for disease management. Previous studies have shown that health management programs based on mobile platforms for patients with diabetes can improve patients' glucose control, self-management ability and quality of life. Type 1 diabetes mellitus (T1DM) due to its characteristics needs long-term linkage care throughout the lifespan cycle of patients. Therefore, this study intends to construct a prospective and open T1DM cohort based on mobile application and platform, to deliver home-community-hospital joint management for patients, and to provide follow-up online or offline every 3 months lasting for 10 years. Mainly, the objective of this study is to observe the blood glucose control outcome of T1DM patients. Secondly, the control of comprehensive metabolic indicators such as blood pressure and blood lipid, occurrence and progression of acute and chronic complications, and psychosocial status were included as well, expecting to provide scientific evidence for continuously improving the quality of T1DM management.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Chinese Smartphone App for 6-18 Years With T1DM - RCT

NCT05418569

Type1 Diabetes Mellitus

UNKNOWN NA

Study on the Improvement of Metabolic Indicators in Type 1 Diabetes Patients

NCT07144696

Type 1 Diabetes Mellitus

RECRUITING NA

Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes

NCT04016987

Type 1 Diabetes

UNKNOWN NA

Evaluation of a Mobile Application to Optimize Self-decision on Metabolic Control in Persons With Type 1 Diabetes

NCT05143411

Diabetes Mellitus, Type 1

COMPLETED NA

Effectiveness of The Health Care CEO App for T1D

NCT05022875

Type 1 Diabetes Mellitus

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 1 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 12 years old;
* Diagnosed as type 1 diabetes according to World Health Organization (WHO) criteria in 1999;
* Be able to use smart mobile phones;
* Informed consent and voluntary participation.

Exclusion Criteria

* Secondary diabetes;
* Complicated with malignant diseases, such as cancer, hepatic and renal failure;
* Complicated with cognitive impairment or mental illness;
* Be pregnant or lactating at the time of enrollment.

Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No